Jul 27, 2026
1:50
For every 50 shares held, investors received 1. The price per share adjusted from $0.57 to $0.01.
The split itself did not change the total investment value.
VYNE Therapeutics Inc. (VYNE) trades on the NASDAQ Global Select in the Biotechnology industry.
VYNE Therapeutics Inc. company overviewThe latest split shown was on July 27, 2026. It was a 1-for-50 reverse split, so shareholders received 1 share for every 50 they held.
This history records 3 reverse splits between February 16, 2021 and July 27, 2026.